Monoclonal antibody injection shown to prevent COVID-19 during Delta, Omicron The relative risk reduction for participants who received adintrevimab as post-exposure prophylaxis was 75%. CIDRAP

A single injection of the monoclonal antibody (mAb), adintrevimab prevented COVID-19 in the phase 2/3 EVADE trial, finds a study yesterday in Open Forum Infectious Diseases.

...

Studies spotlight burnout, online harassment of health workers during COVID-19 CIDRAP

Two new studies illustrate the mental toll COVID-19 took on healthcare workers (HCWs), with the first documenting high rates of burnout among HCWs and the second describing harassment on social media platforms suffered by physicians and scientists during the pandemic.

...

Mpox transmission stays low globally, with mixed regional patterns CIDRAP

Global mpox transmission continues at low levels, though two regions—Southeast Asia and Africa—reported increases in recent weeks, the World Health Organization (WHO) said in its latest update on the outbreak.

Since the last update on May 26, 552 new cases have been reported, reflecting a slight rise of 0.6%. Also, the WHO received reports of four more related deaths.

...

How COVID set back the fight against cancer, and why it’s only getting worse When COVID lockdowns began in early 2020, millions of people went without cancer screenings they otherwise would have gotten. The full cost of this lapse in cancer surveillance is only starting to … colinmeyn The Hill

...physicians fear this screening gap could continue getting wider in the years ahead because of other factors exacerbated by the pandemic, such as health care workforce shortages and altered patient habits. 

...

Millions who had COVID still lack sense of taste or smell, study finds Researchers estimate that about 25% of Americans who had COVID-19 reported only partial or no recovery of their sense of taste or smell. The Seattle Times

...

Researchers at Massachusetts Eye and Ear looked at the loss of olfactory and gustatory senses and estimated that about 25% of Americans who had COVID-19 reported only partial or no recovery of taste or smell.

...

Diabetes drug metformin may cut risk of long COVID - UPI.com Metformin cut the risk of long COVID by about 40% for patients who received a two-week course of the drug while battling their infection, the researchers reported. UPI

...

Britain's COVID-19 inquiry hears government was under-prepared Britain's government was under-prepared and failed to anticipate measures needed to protect the vulnerable, an official inquiry heard on Tuesday, as its chair pledged to put the bereaved at the heart of her work. Alistair Smout Reuters

...

COVID shots should target XBB variants in 2023-24 campaign, US FDA staff say COVID-19 vaccines being developed and manufactured for the 2023-2024 campaign should target one of the currently dominant XBB variants, the U.S. Food and Drug Administration's (FDA) staff reviewers said on Monday. Reuters Reuters

...